OKUR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Onkure Therapeutics Inc (OKUR) is not a strong buy at this time for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of strong trading signals, and no recent news or catalysts make this stock a hold. While technical indicators show a bullish trend, the company's weak financials and lack of significant institutional or insider activity suggest limited upside potential in the near term.
The stock shows a bullish trend with SMA_5 > SMA_20 > SMA_200 and a MACD histogram above 0, though positively contracting. RSI is neutral at 63.138, and the stock is trading near its pivot level of 4.597, with resistance at 5.025 and support at 4.169.
Technical indicators suggest a bullish trend. Historical candlestick pattern analysis indicates an 80% chance of a 6.52% gain in the next day or an 11.59% gain in the next week.
No recent news or event-driven catalysts. Analysts have lowered the price target from $34 to $27 due to an anticipated equity raise.
The company's Q4 2025 financials show no revenue growth (0% YoY), a net income drop to -$13.5M (-61.63% YoY), and a sharp decline in EPS to -0.99 (-89.42% YoY).
H.C. Wainwright maintains a Buy rating but lowered the price target from $34 to $27, factoring in an equity raise in Q2.
